Moreover, IP3R2/IP3R3 upregulation in breast tumors correlated with an increase in lipoproteins and several metabolites (such as lactate, alanine, and lysine) in the serum of these patients compared to breast cancer patients with low IP3R2/IP3R3 levels or healthy controls (124). This evidence concerns the gene ITPR2 and breast cancer.